Fianlimab + Libtayo
Melanoma (1L adjuvant & advanced)
Key Facts
Indication
Melanoma (1L adjuvant & advanced)
Phase
Phase 3
Status
Active, recruiting
Company
About Regeneron Pharmaceuticals
Regeneron is a premier biotechnology company with a mission to translate groundbreaking science into life-changing medicines for patients. Its achievements are anchored by its proprietary VelociSuite® technology platforms, which have enabled the development of a robust commercial portfolio and one of the industry's deepest pipelines. The company's strategy combines sustained internal R&D investment with selective, high-value collaborations, all supported by a fully integrated model from discovery to global commercialization.
View full company profile